| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.
|
Am J Hum Genet
|
2008
|
2.21
|
|
2
|
Manipulating phospholipids for crystallization of a membrane transport protein.
|
Proc Natl Acad Sci U S A
|
2006
|
1.71
|
|
3
|
A novel role of the C-terminus of b 0,+ AT in the ER-Golgi trafficking of the rBAT-b 0,+ AT heterodimeric amino acid transporter.
|
Biochem J
|
2009
|
1.41
|
|
4
|
Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
|
Anticancer Res
|
2010
|
1.20
|
|
5
|
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).
|
Hepatology
|
2014
|
1.19
|
|
6
|
System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.
|
Cancer Lett
|
2008
|
1.08
|
|
7
|
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
|
J Nucl Med
|
2012
|
1.02
|
|
8
|
The Sec-independent function of Escherichia coli YidC is evolutionary-conserved and essential.
|
J Biol Chem
|
2005
|
1.02
|
|
9
|
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
|
BMC Cancer
|
2013
|
0.97
|
|
10
|
SecY alterations that impair membrane protein folding and generate a membrane stress.
|
J Cell Biol
|
2007
|
0.97
|
|
11
|
Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
|
J Pharmacol Sci
|
2012
|
0.95
|
|
12
|
Functional overlap but lack of complete cross-complementation of Streptococcus mutans and Escherichia coli YidC orthologs.
|
J Bacteriol
|
2008
|
0.95
|
|
13
|
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.
|
Histopathology
|
2014
|
0.94
|
|
14
|
Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
|
Cancer Sci
|
2014
|
0.88
|
|
15
|
Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
|
Hepatol Res
|
2014
|
0.86
|
|
16
|
A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules.
|
J Biol Chem
|
2010
|
0.85
|
|
17
|
NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout.
|
Arthritis Rheumatol
|
2015
|
0.84
|
|
18
|
NRFL-1, the C. elegans NHERF orthologue, interacts with amino acid transporter 6 (AAT-6) for age-dependent maintenance of AAT-6 on the membrane.
|
PLoS One
|
2012
|
0.81
|
|
19
|
Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
|
Int J Cancer
|
2013
|
0.81
|
|
20
|
L-glutamate enhances methylmercury toxicity by synergistically increasing oxidative stress.
|
J Pharmacol Sci
|
2008
|
0.81
|
|
21
|
Glycolipozyme MPIase is essential for topology inversion of SecG during preprotein translocation.
|
Proc Natl Acad Sci U S A
|
2013
|
0.80
|
|
22
|
YY1 binds to α-synuclein 3'-flanking region SNP and stimulates antisense noncoding RNA expression.
|
J Hum Genet
|
2013
|
0.80
|
|
23
|
Linkage of N-cadherin to multiple cytoskeletal elements revealed by a proteomic approach in hippocampal neurons.
|
Neurochem Int
|
2012
|
0.80
|
|
24
|
Nicotine induces dendritic spine remodeling in cultured hippocampal neurons.
|
J Neurochem
|
2013
|
0.80
|
|
25
|
Identification of a hypouricemia patient with SLC2A9 R380W, a pathogenic mutation for renal hypouricemia type 2.
|
Nucleosides Nucleotides Nucleic Acids
|
2014
|
0.78
|
|
26
|
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
|
Melanoma Res
|
2015
|
0.78
|
|
27
|
Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2.
|
Cancer Sci
|
2015
|
0.77
|
|
28
|
Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
|
Ann Nucl Med
|
2013
|
0.77
|
|
29
|
Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
|
Pathol Oncol Res
|
2015
|
0.76
|
|
30
|
[Amino acid transporters in cancer].
|
Seikagaku
|
2014
|
0.75
|